We are live on ! Find out more
BCAX

Bicara Therapeutics
BCAX

69 hedge funds and large institutions have $928M invested in Bicara Therapeutics in 2024 Q3 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

66.96% more ownership

Funds ownership: 0% → 66.96% (+67%)

Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
0.99%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$177M
2
TGA
TPG GP A
Texas
+$76.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$58M
4
OFM
Omega Fund Management
Massachusetts
+$56.2M
5
DM
Deerfield Management
New York
+$45.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$340K +$340K +13,341 New
GCM
52
Greenland Capital Management
New York
$313K +$314K +12,296 New
Jane Street
53
Jane Street
New York
$309K +$310K +12,151 New
CC
54
Caxton Corporation
New Jersey
$279K +$279K +10,941 New
DKCM
55
Davidson Kempner Capital Management
New York
$255K +$255K +10,000 New
Barclays
56
Barclays
United Kingdom
$255K +$255K +10,000 New
GCM
57
Ghisallo Capital Management
Massachusetts
$255K +$255K +10,000 New
CCM
58
Cinctive Capital Management
New York
$229K +$230K +9,001 New
Two Sigma Investments
59
Two Sigma Investments
New York
$229K +$230K +9,000 New
Federated Hermes
60
Federated Hermes
Pennsylvania
$204K +$204K +8,000 New
UBS Group
61
UBS Group
Switzerland
$71.1K +$71.2K +2,790 New
Morgan Stanley
62
Morgan Stanley
New York
$50.9K +$51K +2,000 New
JP Morgan Chase
63
JP Morgan Chase
New York
$18.6K +$18.6K +730 New
ACM
64
Aster Capital Management
United Arab Emirates
$18.4K +$18.4K +722 New
Citigroup
65
Citigroup
New York
$6.42K +$6.43K +252 New
KIG
66
Kessler Investment Group
Indiana
$5.09K +$5.1K +200 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$3K +$2.55K +100 New
Osaic Holdings
68
Osaic Holdings
Arizona
$942 +$944 +37 New
MCI
69
MRP Capital Investments
Georgia
$510 +$510 +20 New
1 2
3

BCAX Hedge Fund Activity: Q3 2024 in Review

69 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bicara Therapeutics (BCAX) for Q3 2024, worth a combined $928M.

Buyers outnumbered sellers: 69 funds opened new BCAX positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $177M.

  • 69 institutional investors held Bicara Therapeutics (BCAX) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $928M of Bicara Therapeutics stock for Q3 2024.
  • 69 funds opened new Bicara Therapeutics positions in Q3 2024 and 0 closed out, a net change of +69 holders.
  • The largest Bicara Therapeutics buyer in Q3 2024 was RA Capital Management, an estimated $177M added.

Based on aggregated 13F filings for Q3 2024.